Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to...
279 insider purchases on record · latest filing 2019-07-03.
Insiders have also filed 998 sale transactions at ADPT.